Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
about
The Role of PPARs in CancerPPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesisPPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsClinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumoursPax-8-PPAR-γ fusion protein in thyroid carcinomaRole of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cellsPeroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinomaProteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interactionAnticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγHic-5 regulates an epithelial program mediated by PPARgammaPeroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transitionIn vitro and in vivo cytotoxicity of troglitazone in pancreatic cancerA ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcomaPPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaMinireview: Challenges and opportunities in development of PPAR agonistsTherapeutic Implications of PPARgamma in Human Osteosarcoma.Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.Peroxisome proliferator-activated receptors in the cardiovascular system.15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinomaRepression of beta-catenin function in malignant cells by nonsteroidal antiinflammatory drugsA phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.Telmisartan inhibits human urological cancer cell growth through early apoptosis.Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancerRisk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer.Defective osteogenic differentiation in the development of osteosarcoma.PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancerPPAR-gamma receptor ligands: novel therapy for pituitary adenomas.A joint effect of new Western diet and retinoid X receptor α prostate-specific knockout with development of high-grade prostatic intraepithelial neoplasia in mice--a preliminary study.Expression of peroxisome proliferator-activated receptor γ in rat retina during development.15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in ratsStratified epithelial sheets engineered from a single adult murine corneal/limbal progenitor cell.Cancer chemopreventive ability of conjugated linolenic acids.Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells
P2860
Q21342955-4BE95497-B317-4193-9BDA-6A878575FAFAQ24553314-FEABC593-2A34-43C8-8526-5C826B347137Q28066756-A1407EDC-E783-4563-A9F1-2FA36BB1CE25Q28209267-455F2005-E61E-4C73-8B79-87114D995DC9Q28244806-DCFCCB45-F5D5-42FE-85BB-B068625E27A3Q28345289-408A1EAC-D856-4B3F-8391-8192F255D2EEQ28366616-F1AFED83-4684-4D3E-B854-EB758E2531EDQ28484038-AC436D51-46EE-4DC5-BD72-269BAA41F647Q28541836-0EED8262-9C39-49D9-BA4D-4E74E907E4FAQ28586821-C0DDA9F4-1E0C-4A06-BCC7-3E72C5462901Q30498249-A0281888-97D4-4CA6-A0EC-6787875C7BECQ32174263-88F7E00E-761E-4628-93C5-464A2F155F5DQ33183474-DDF4655A-F341-4E72-BD65-441F385D2D29Q33183686-6EE19B6E-E7D9-4493-A377-1FB7A2A96172Q33235601-643CC11C-7E09-45AE-8860-EDE240C432BDQ33631921-ADFE122D-1A5D-4576-ACDE-E7B9355DB656Q33674615-CB90B7F1-A3FA-4164-AA1C-B930AC51965FQ33736242-D53788AC-42AB-489D-8F2F-E4E46D43BE59Q33809071-F89CEDC7-843A-487C-AE9F-E4C1E125CEC2Q33850995-159A3E4F-D9B7-4C54-B77B-9B556E0C10E7Q33867006-1C4D64E4-FC5D-4FCA-802B-DD9F6AC3B83EQ34234828-9BE22A90-329D-461F-A169-C4C9ED2AE07BQ34262817-9272D7A9-BAE4-4804-ABEA-6A9DEB07ED4EQ34277079-ECEB0935-5C11-4C54-AA54-7E5ACE7FBD75Q34418476-5F5FF66A-A796-42B4-AB8C-88F401E773B7Q34420463-E5CD9833-5895-4FE9-8834-745871C86136Q34462138-02C60131-694A-49E7-BE65-AFF720D1E4CBQ34628009-525ABE10-CBA3-4300-9A0E-379CF0C47D76Q34646050-16E5F4C1-CEF6-408D-85D2-83900F1DA6ADQ34700590-3767C166-59A9-42EB-ABDE-62A500592191Q34768343-F7A03965-8E13-4050-8D29-272533F75EF8Q34985044-2A4E6A54-113B-435D-8E5E-199942E07B20Q35064428-17677DFC-4BA8-41A7-9E30-133617210828Q35075364-B572CA32-26F1-4566-A6EE-BA063FD4FF70Q35126551-0BE21A36-412E-4D39-8122-F1F7D7486C09Q35575604-5E8F9C79-90B5-4E8A-811F-5027B41E88F0Q35600117-82755A7E-0C88-41E9-84CD-0E8D15A2FA87Q35750111-92B1FE5C-A416-42BB-AD7C-69B68339295CQ35817986-966C5FDF-591C-4808-8B98-C09F3A190AADQ36099516-6F5DCF87-06BE-4245-990F-E3BF1328388A
P2860
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Ligand for peroxisome prolifer ...... cer both in vitro and in vivo.
@en
type
label
Ligand for peroxisome prolifer ...... cer both in vitro and in vivo.
@en
prefLabel
Ligand for peroxisome prolifer ...... cer both in vitro and in vivo.
@en
P2093
P1433
P1476
Ligand for peroxisome prolifer ...... ncer both in vitro and in vivo
@en
P2093
Koeffler HP
Koshizuka K
Williamson EA
P304
P407
P577
1998-08-01T00:00:00Z